Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells

Biochemical and Biophysical Research Communications

Volumn 280, Issue 5, 2001, Pages 1216-1223

  Kawabata, Shigeru ^a   Oka, Mikio ^a   Shiozawa, Ken ^a   Tsukamoto, Kazuhiro ^a   Nakatomi, Katsumi ^a   Soda, Hiroshi ^a   Fukuda, Minoru ^a   Ikegami, Yoji ^b   Sugahara, Kazuyuki ^a   Yamada, Yasuaki ^a   Kamihira, Shimeru ^a   Doyle, L Austin ^c   Ross, Douglas D ^c,d   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

ABC transporter; Antisense oligonucleotide; Drug resistance; Half transporter; Lung cancer; Multidrug resistance; Topoisomerase I inhibitor

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ABC TRANSPORTER; ANTISENSE OLIGONUCLEOTIDE; BREAST CANCER RESISTANCE PROTEIN; CAMPTOTHECIN DERIVATIVE; CISPLATIN; DOXORUBICIN; IRINOTECAN; MESSENGER RNA; MITOXANTRONE; TOPOTECAN; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG TRANSPORT; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0034817098     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4267     Document Type: Article

References (36)

1. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
2. The multidrug resistance protein family
3. An inventory of the human ABC proteins
4. A multidrug resistance transporter from huamn MCF-7 breast cancer cells
5. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein
6. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
7. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
8. Atypical multidrug resistance: Breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines
9. The mouse Bcrp1/Mxr/Abcp gene: Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin
10. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line
11. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line
12. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C
13. Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell lines is not due to DNA topoisomerase I alterations
14. Camptothecin resistance: Role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells
15. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
16. The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro
17. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant
18. Reduced cellular accumulation of topotecan: A novel mechanism of resistance in a human ovarian cancer cell line
19. ATP-dependent afflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P
20. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
21. Expression of the UDP-glucuronosyltransferase 1A locus in human colon
22. A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene
23. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells
24. High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT
25. Expression of wild-type p53 during the cell cycle in normal human mammary epithelial cells
26. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells
27. Cloning to two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells
28. Biliary excretion mechanism of CPT-11 and its metabolites in humans: Involvement of primary active transporters
29. Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion
30. Glucuronidation of 7-etyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus
31. Genetic predisposition to the metabolism of irinotecan (CPT-11)
32. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257
33. Novel mechanisms of drug resistance in leukemia
34. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines
35. Phase I study of irinotecan combined with carboplatin in previously untreated solid cancers